Study shows mRNA-based COVID vaccines enhance effectiveness of immune checkpoint therapy Patients with cancer who received mRNA-based COVID vaccines within 100 days of starting immune checkpoint therapy were twice as likely to be alive three years after beginning treatment, according to a new study led by researchers at The University of Texas MD Anderson Cancer Center.
https://www.news-medical.net/n....ews/20251022/Study-s